NFKB1 and myalgic encephalomeyelitis/chronic fatigue syndrome: We can conclude that the increase in expression of these three gene transcripts in the ME/CFS group implies an underlying biological counter-attempt to control unwanted excess activity of NF-κB and inflammation in ME/CFS, driven by TNFα.